Membership
Tour
Register
Log in
Frank S. Menniti
Follow
Person
Mystic, CT, US
People
Overview
Industries
Organizations
People
Information
Impact
Patents Grants
last 30 patents
Information
Patent Grant
Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B
Patent number
12,161,624
Issue date
Dec 10, 2024
Novartis AG
David R. Anderson
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Heteroaromatic NMDA receptor modulators and uses thereof
Patent number
12,162,890
Issue date
Dec 10, 2024
Novartis AG
David R. Anderson
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[C]pyrrole negative allos...
Patent number
12,145,909
Issue date
Nov 19, 2024
Novartis AG
David R. Anderson
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
NMDA receptor modulators and uses thereof
Patent number
11,807,650
Issue date
Nov 7, 2023
Novartis AG
David R. Anderson
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Thienopyrimidinone NMDA receptor modulators and uses thereof
Patent number
11,648,253
Issue date
May 16, 2023
Novartis AG
David R. Anderson
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Thienopyrimidinone NMDA receptor modulators and uses thereof
Patent number
11,541,057
Issue date
Jan 3, 2023
Cadent Therapeutics, Inc.
David R. Anderson
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
NMDA receptor modulators and uses thereof
Patent number
11,274,107
Issue date
Mar 15, 2022
Cadent Therapeutics, Inc.
David R. Anderson
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Heteroaromatic NMDA receptor modulators and uses thereof
Patent number
11,236,104
Issue date
Feb 1, 2022
Cadent Therapeutics, Inc.
David R. Anderson
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B
Patent number
11,116,749
Issue date
Sep 14, 2021
Cadent Therapeutics, Inc.
David R. Anderson
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Thienopyrimidinone NMDA receptor modulators and uses thereof
Patent number
10,973,825
Issue date
Apr 13, 2021
Cadent Therapeutics, Inc.
David R. Anderson
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[C]pyrrole negative allos...
Patent number
10,781,174
Issue date
Sep 22, 2020
Cadent Therapeutics, Inc.
David R. Anderson
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Heteroaromatic NMDA receptor modulators and uses thereof
Patent number
10,626,122
Issue date
Apr 21, 2020
Cadent Therapeutics, Inc.
David R. Anderson
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Thienopyrimidinone NMDA receptor modulators and uses thereof
Patent number
10,500,205
Issue date
Dec 10, 2019
Cadent Therapeutics, Inc.
David R. Anderson
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[c]pyrrole negative allos...
Patent number
10,239,835
Issue date
Mar 26, 2019
Cadent Therapeutics, Inc.
David R. Anderson
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B
Patent number
10,052,306
Issue date
Aug 21, 2018
Cadent Therapeutics, Inc.
David R. Anderson
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B
Patent number
9,540,324
Issue date
Jan 10, 2017
LUC THERAPEUTICS, INC.
David R. Anderson
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Imidazole derivatives
Patent number
7,078,529
Issue date
Jul 18, 2006
Pfizer Inc.
Mark A. Sanner
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
NMDA NR2B antagonists for treatment
Patent number
7,019,016
Issue date
Mar 28, 2006
Pfizer Inc.
Bertrand L. Chenard
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
NMDA NR2B antagonists for treatment
Patent number
6,958,351
Issue date
Oct 25, 2005
Pfizer Inc.
Bertrand L. Chenard
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Pharmaceutical combinations for the treatment of stroke and traumat...
Patent number
6,821,985
Issue date
Nov 23, 2004
Pfizer, Inc.
Bertrand L. Chenard
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Imidazole derivatives
Patent number
6,756,385
Issue date
Jun 29, 2004
Pfizer Inc.
Mark A. Sanner
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Pharmaceutical combinations for the treatment of stroke and traumat...
Patent number
6,667,317
Issue date
Dec 23, 2003
Pfizer Inc.
Bertrand L. Chenard
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Combinations for the treatment of parkinsonism containing selective...
Patent number
6,258,827
Issue date
Jul 10, 2001
Pfizer Inc.
Bertrand L. Chenard
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Methods of administering AMPA receptor antagonists to treat dyskine...
Patent number
6,136,812
Issue date
Oct 24, 2000
Pfizer Inc.
Bertrand L. Chenard
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Patents Applications
last 30 patents
Information
Patent Application
NMDA RECEPTOR MODULATORS AND USES THEREOF
Publication number
20240294546
Publication date
Sep 5, 2024
Novartis AG
David R. Anderson
C07 - ORGANIC CHEMISTRY
Information
Patent Application
HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF
Publication number
20230023543
Publication date
Jan 26, 2023
Cadent Therapeutics, Inc.
David R. Anderson
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
SELECTIVE OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE MODULATORS OF NR2B
Publication number
20230012073
Publication date
Jan 12, 2023
Cadent Therapeutics, Inc.
David R. Anderson
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOS...
Publication number
20220274925
Publication date
Sep 1, 2022
CADENT THERAPEUTICS, INC.
David R. Anderson
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
NMDA RECEPTOR MODULATORS AND USES THEREOF
Publication number
20220153755
Publication date
May 19, 2022
Cadent Therapeutics, Inc.
David R. Anderson
C07 - ORGANIC CHEMISTRY
Information
Patent Application
THIENOPYRIMIDINONE NMDA RECEPTOR MODULATORS AND USES THEREOF
Publication number
20220047600
Publication date
Feb 17, 2022
Cadent Therapeutics, Inc.
David R. Anderson
C07 - ORGANIC CHEMISTRY
Information
Patent Application
THIENOPYRIMIDINONE NMDA RECEPTOR MODULATORS AND USES THEREOF
Publication number
20220016117
Publication date
Jan 20, 2022
Cadent Therapeutics, Inc.
David R. Anderson
C07 - ORGANIC CHEMISTRY
Information
Patent Application
DENDRITIC CELL RECRUITMENT FROM BLOOD TO BRAIN IN NEURODEGENERATIVE...
Publication number
20210181185
Publication date
Jun 17, 2021
MINDIMMUNE THERAPEUTICS, INC.
Brian Michael Campbell
G01 - MEASURING TESTING
Information
Patent Application
HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF
Publication number
20210107916
Publication date
Apr 15, 2021
Cadent Therapeutics, Inc.
David R. Anderson
C07 - ORGANIC CHEMISTRY
Information
Patent Application
N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOS...
Publication number
20200369610
Publication date
Nov 26, 2020
Cadent Therapeutics, Inc.
David R. Anderson
C07 - ORGANIC CHEMISTRY
Information
Patent Application
NMDA RECEPTOR MODULATORS AND USES THEREOF
Publication number
20200087323
Publication date
Mar 19, 2020
Cadent Therapeutics, Inc.
David R. Anderson
C07 - ORGANIC CHEMISTRY
Information
Patent Application
N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOS...
Publication number
20190152912
Publication date
May 23, 2019
Cadent Therapeutics, Inc.
David R. Anderson
C07 - ORGANIC CHEMISTRY
Information
Patent Application
SELECTIVE OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE MODULATORS OF NR2B
Publication number
20180325868
Publication date
Nov 15, 2018
Cadent Therapeutics, Inc.
David R. Anderson
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOS...
Publication number
20180111902
Publication date
Apr 26, 2018
Luc Therapeutics, Inc.
David R. ANDERSON
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
SELECTIVE OCTAHYDRO-CYCLOPENTA[C] PYRROLE NEGATIVE MODULATORS OF NR2B
Publication number
20170071906
Publication date
Mar 16, 2017
LUC THERAPEUTICS, INC.
David R. Anderson
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
SELECTIVE OCTAHYDRO-CYCLOPENTA[C] PYRROLE NEGATIVE MODULATORS OF NR2B
Publication number
20150225342
Publication date
Aug 13, 2015
Mnemosyne Pharmaceuticals, Inc.
David R. Anderson
C07 - ORGANIC CHEMISTRY
Information
Patent Application
Imidazole derivatives
Publication number
20060149066
Publication date
Jul 6, 2006
Pfizer Inc.
Mark A. Sanner
C07 - ORGANIC CHEMISTRY
Information
Patent Application
PDE 10 cell-based assay and sequences
Publication number
20050026236
Publication date
Feb 3, 2005
Pfizer Inc.
Larry C. James
G01 - MEASURING TESTING
Information
Patent Application
NMDA NR2B antagonists for treatment
Publication number
20040192763
Publication date
Sep 30, 2004
Pfizer, Inc.
Bertrand L. Chenard
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
Imidazole derivatives
Publication number
20040192750
Publication date
Sep 30, 2004
Pfizer Inc.
Mark A. Sanner
C07 - ORGANIC CHEMISTRY
Information
Patent Application
Therapeutic use of selective PDE10 inhibitors
Publication number
20040162293
Publication date
Aug 19, 2004
Pfizer Inc.
Lorraine A. Lebel
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
Therapeutic use of selective PDE10 inhibitors
Publication number
20040162294
Publication date
Aug 19, 2004
Pfizer Inc.
Lorraine A. Lebel
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
Disruption of the phosphodiesterase 10 gene
Publication number
20030121069
Publication date
Jun 26, 2003
Pfizer Inc.
Frank S. Menniti
A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information
Patent Application
PDE10 cell-based assay and sequences
Publication number
20030096323
Publication date
May 22, 2003
Pfizer Inc.
Larry C. James
G01 - MEASURING TESTING
Information
Patent Application
Therapeutic use of selective PDE10 inhibitors
Publication number
20030032579
Publication date
Feb 13, 2003
Pfizer Inc.
Lorraine A. Lebel
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information
Patent Application
Therapeutic use of selective PDE10 inhibitors
Publication number
20030018047
Publication date
Jan 23, 2003
Pfizer Inc.
Lorraine A. Lebel
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information
Patent Application
Therapeutic use of selective PDE10 inhibitors
Publication number
20030008806
Publication date
Jan 9, 2003
Pfizer Inc.
Lorraine A. Lebel
G01 - MEASURING TESTING
Information
Patent Application
Pharmaceutical combinations for the treatment of stroke and traumat...
Publication number
20020123510
Publication date
Sep 5, 2002
Pfizer Inc.
Bertrand L. Chenard
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
Imidazole derivatives
Publication number
20020119963
Publication date
Aug 29, 2002
Mark A. Sanner
C07 - ORGANIC CHEMISTRY
Information
Patent Application
Prophylactic use of N-methyl-D-aspartate (NMDA) antagonists
Publication number
20020072485
Publication date
Jun 13, 2002
Bertrand L. Chenard
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE